Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Archives of Biochemistry and Biophysics
|
October 29, 2025
Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929]
Yue Lai, Shushan Guo, Qiongwei Tang, et al.
Archives of Biochemistry and Biophysics
|
February 17, 2024
Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma
Yue Lai, Shushan Guo, Qiongwei Tang, et al.
International Immunopharmacology
|
June 22, 2024
Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139]
Qilin Feng, Ke Hu, Huifang Hu, et al.
Cancer Letters
|
March 13, 2020
A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib
Gege Chen, Ke Hu, Haiguo Sun, et al.
Signal Transduction and Targeted Therapy
|
April 17, 2020
A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway
Kang Lu, Bo Li, Hui Zhang, et al.
Acta Biochimica Et Biophysica Sinica
|
April 5, 2019
DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma
Ting Zhang, Bo Li, Qilin Feng, et al.
International Journal of Biological Sciences
|
January 2, 2025
Aberrant activation of adenine nucleotide translocase 3 promotes progression and chemoresistance in multiple myeloma dependent on PINK1 transport
Ke Hu, Yue Lai, Jinfeng Zhou, et al.
Oncogene
|
March 14, 2026
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation
Guanli Wang, Xuejie Gao, Hui Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 11, 2020
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
Liangning Hu, Bo Li, Gege Chen, et al.
Journal of Biomedical Science
|
May 13, 2022
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma
Yongsheng Xie, Yingcong Wang, Zhijian Xu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Archives of Biochemistry and Biophysics
|
October 29, 2025
Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929]
Yue Lai, Shushan Guo, Qiongwei Tang, et al.
Archives of Biochemistry and Biophysics
|
February 17, 2024
Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma
Yue Lai, Shushan Guo, Qiongwei Tang, et al.
International Immunopharmacology
|
June 22, 2024
Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139]
Qilin Feng, Ke Hu, Huifang Hu, et al.
Cancer Letters
|
March 13, 2020
A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib
Gege Chen, Ke Hu, Haiguo Sun, et al.
Signal Transduction and Targeted Therapy
|
April 17, 2020
A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway
Kang Lu, Bo Li, Hui Zhang, et al.
Acta Biochimica Et Biophysica Sinica
|
April 5, 2019
DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma
Ting Zhang, Bo Li, Qilin Feng, et al.
International Journal of Biological Sciences
|
January 2, 2025
Aberrant activation of adenine nucleotide translocase 3 promotes progression and chemoresistance in multiple myeloma dependent on PINK1 transport
Ke Hu, Yue Lai, Jinfeng Zhou, et al.
Oncogene
|
March 14, 2026
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation
Guanli Wang, Xuejie Gao, Hui Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 11, 2020
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
Liangning Hu, Bo Li, Gege Chen, et al.
Journal of Biomedical Science
|
May 13, 2022
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma
Yongsheng Xie, Yingcong Wang, Zhijian Xu, et al.
Page
of 5